Ayça Arslan

Dr. Ayça Arslan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
MKMuammer Karakayalı
Muammer Karakayalı
MAMehmet Altunova
Mehmet Altunova
TYTurab Yakisan
Turab Yakisan
SASerkan Aslan
Serkan Aslan
TOTimor Omar
Timor Omar
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
Resumo Fundamento: A isquemia com artéria coronária não obstrutiva (INOCA) é uma doença cardíaca isquêmica que inclui principalmente disfunção microvascular coronariana e/ou vasoespasmo coronariano epicárdico devido à disfunção vascular coronariana subjacente e pode ser observada mais comumente em pacientes do sexo feminino. O índice de inflamação imunológica sistêmica (SII, relação plaquetas × neutrófilos/linfócitos) é um novo marcador que prediz resultados clínicos adversos na doença arterial coronariana (DAC). Objetivo: Este estudo tem como objetivo investigar a relação entre INOCA e SII, [...] Resumo Fundamento: A isquemia com artéria coronária não obstrutiva (INOCA) é uma doença cardíaca isquêmica que inclui principalmente disfunção microvascular coronariana e/ou vasoespasmo coronariano epicárdico devido à disfunção vascular coronariana subjacente e pode ser observada mais comumente em pacientes do sexo feminino. O índice de inflamação imunológica sistêmica (SII, relação plaquetas × neutrófilos/linfócitos) é um novo marcador que prediz resultados clínicos adversos na doença arterial coronariana (DAC). Objetivo: Este estudo tem como objetivo investigar a relação entre INOCA e SII,

26 February 2025 in Biomarkers in Medicine
Verified
Journal Article
Closed access
DIDOGAN ILIS
DOGAN ILIS
AAAyça Arslan
Ayça Arslan
IAinanc artac
inanc artac
MKMuammer Karakayalı
Muammer Karakayalı
TOTimor Omar
Timor Omar
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
We aimed to investigate the association between the HALP score and in-hospital mortality in patients with non-ST segment myocardial infarction (NSTEMI). In this retrospective study participants were divided into two groups, based on the median HALP score. Findings were compared between the groups. A total of 1648 patients included. The median HALP score cutoff value was 3.87. While the low HALP score group (3.87) included 824 patients. Patients with the low HALP score were older and had a higher prevalence of comorbidities. A HALP score ≤ 2.62 predicted in-hospital mortality with sensitivity of 72.5% and a specificity of 77.3% (area under curve 0.809), according to ROC curve analysis. In multivariate analysis, age, diastolic blood pressure, Killip Class > 1 and Syntax Score, creatinine level, LVEF and HALP Score (OR: 0.504, 95% CI: 0.415-0.613; p < 0.001) were independently associated with in-hospital mortality. According to the current study, the HALP score was independently associated with in-hospital mortality in patients with NSTEMI. Moreover, HALP score might be used as a predictor of in-hospital mortality in this population.

31 July 2024 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
IAinanc artac
inanc artac
DIDOGAN ILIS
DOGAN ILIS
MKMuammer Karakayalı
Muammer Karakayalı
TOTimor Omar
Timor Omar
AAAyça Arslan
Ayça Arslan
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları

1 January 2024 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Closed access
AAAyça Arslan
Ayça Arslan
This study explores the impact of sST2, Growth Differentiation Factor 15 (GDF-15), and clinical factors on cognitive dysfunction in elderly patients with heart failure with reduced ejection fraction (HFrEF). A cohort of 101 chronic stable HFrEF patients aged over 65 years old participated in the study. Cognitive functions were assessed using the Montreal Cognitive Assessment (MoCA) test and the Mini Mental State Examination (MMSE). Levels of sST2, GDF-15, and N-terminal pro b-type natriuretic peptide (NT-proBNP) were also measured. Notably higher levels of NT-proBNP and GDF-15 were observed in the group with cognitive dysfunction, whereas sST2 levels were similar between the groups. The cognitive dysfunction group consisted of older patients. A higher proportion of patients with normal cognitive function had received influenza vaccinations. Furthermore, GDF-15 levels inversely correlated with MMSE score. Right ventricular diameter was negatively correlated, while hemoglobin levels were positively correlated with both MoCA and MMSE scores. Logistic regression analysis identified increased GDF-15 levels, older age, and advanced New York Heart Association (NYHA) classes as predictors of higher cognitive dysfunction risk, whereas influenza vaccination was linked to a reduced risk of cognitive dysfunction. Cognitive dysfunction in elderly patients with heart failure may be influenced by factors such as age, right ventricular enlargement, anemia, NYHA functional class, and levels of GDF-15 and NT-proBNP.

13 July 2022 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Closed access
AAAyça Arslan
Ayça Arslan
KFKardiyoloji Anabilim Dali Mersin Universitesi Tip Fakultesi
Kardiyoloji Anabilim Dali Mersin Universitesi Tip Fakultesi
DYDilek Cicek Yilmaz
Dilek Cicek Yilmaz
MAMuhammed Adiyaman
Muhammed Adiyaman
CKCelal Kara
Celal Kara
NFNoroloji Anabilim Dali Mersin Universitesi Tip Fakultesi
Noroloji Anabilim Dali Mersin Universitesi Tip Fakultesi
Objective: Cryptogenic stroke (CS) is considered to be the most common stroke subtype in young patients. The Risk of Paradoxical Embolism (RoPE) score is a tool that stratifies patients with CS according to the probability of patent foramen ovale (PFO). The aim of this retrospective study is to determine the prevalence of PFO in young patients with transesophageal echocardiography (TEE) and to evaluate the role of RoPE score in PFO-related strokes. Methods: The medical records of patients with acute arterial ischemic stroke, who underwent TEE between 2016 and 2020, were reviewed. Patients aged 18-55 years were included in the study. Presence of PFO, PFO characteristics, presence of atrial septal aneurysm (ASA) were detected by examining the image records of the patients from the archive system. RoPE score was calculated for all patients as determined in the literature. Results: Totally, 50 CS patients were included in the study (mean age: 39.6 +/- 9.4 years). PFO was detected in 19 (38%) patients and it was the most common cardiac abnormality in CS patients. ASA was detected in 7 (14%) patients. The mean RoPE score in patients with PFO was higher than patients without PFO, although it did not reach statistical significance (7.68 +/- 1.1 versus 6.77 +/- 1.9 P = .07). Eighteen of 19 patients with PFO had a RoPE score >= 7. Conclusion: In our study, PFO prevalence in the CS patients was higher than normal population. In patients with cryptogenic stroke, the RoPE score can help determine the probability of PFO related stroke and which patients should undergo TEE.

1 May 2025 in Vasa
Verified
Journal Article
Closed access
MKMuammer Karakayalı
Muammer Karakayalı
IAinanc artac
inanc artac
DIDOGAN ILIS
DOGAN ILIS
TOTimor Omar
Timor Omar
AAAyça Arslan
Ayça Arslan
IRIbrahim Rencüzoğulları
Ibrahim Rencüzoğulları
Summary: Background: Percutaneous superficial femoral interventions remain the preferred method of treatment for superficial femoral artery (SFA) disease. Nevertheless, long term restenosis continues to be a major limitation of percutaneous interventions. In this context, the objective of this study is to compare the efficacies of CHA2DS2-VASc, CHA2DS2-VASc-HS, ATRIA, ATRIA-HSV, and HATCH risk scoring systems in predicting long-term (5 years) restenosis due to percutaneous interventions to the superficial femoral artery. Patients and methods: The sample of this retrospective study consisted of 545 peripheral artery disease (PAD) patients with a percutaneous intervention to the SFA. Of these patients, 362 and 183 were included in the group of PAD patients without long-term (5 years) SFA restenosis (Group 1) and in the group of PAD patients with long-term SFA restenosis (Group 2). The efficacies of CHA2DS2-VASc, CHA2DS2-VASc-HS, ATRIA, ATRIA-HSV, and HATCH risk scoring systems in predicting the development of long-term SFA restenosis were comparatively analyzed. Results: CHA2DS2-VASc, CHA2DS2-VASc-HS, ATRIA, ATRIA-HSV, and HATCH risk scores all increased with long-term SFA restenosis. The receiver operating characteristic (ROC) curve analysis revealed that all five risk scoring systems successfully predicted long-term SFA restenosis, whereas the paired ROC curve analysis revealed that CHA2DS2-VASc-HS scores of >4 had the best prognostic power in predicting long term SFA restenosis. Conclusions: The study findings indicated that the CHA2DS2-VASc-HS score was an independent predictor of the development of SFA restenosis. The CHA2DS2-VASc-HS risk scoring system, which is the modified version of CHA2DS2-VASc, outperformed the CHA2DS2-VASc, HATCH, ATRIA, and ATRIA-HSV, the modified version of ATRIA, risk scoring systems in predicting long-term (5 years) SFA restenosis.